CXT
Crane NXT, Co.
CXT's fundamentals are mixed, but it looks expensive: trading at 26x earnings, above its usual 19x. Analysts expect earnings growth.
CXT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Under pressure |
CXT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
CXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $56.99 | — |
| Cheap | 15x | $32.96 | -42% |
| Fair | 19x | $41.21 | -28% |
| Current | 26x | $56.99 | — |
| Expensive | 27x | $60.07 | +5.4% |
Historical ranges are pointers, not guarantees.
CXT's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.
CXT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CXT, but weaker profitability.
CXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | +108% |
| Q3 2026 | $2.20 | -18% |
| Q2 2026 | $2.41 | -8% |
| Q1 2026 | $2.23 | -23% |
| Q4 2025 | $2.50 | -22% |
| Q3 2025 | $2.68 | -12% |
| Q2 2025 | $2.62 | -17% |
| Q1 2025 | $2.91 | -8.2% |
| Q4 2022 | $2.43 | -4.7% |
CXT's earnings per share have fallen from their peak: $2.20 over the past year, against $3.31 in mid-2022.
CXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $497.1M | +12% |
| Q2 2026 | $493.2M | +22% |
| Q1 2026 | $387.7M | +17% |
| Q4 2025 | $476.9M | +19% |
| Q3 2025 | $445.1M | +10% |
| Q2 2025 | $404.4M | +9.1% |
| Q1 2025 | $330.3M | +5.3% |
| Q4 2024 | $399.1M | +12% |
CXT's revenue has grown year over year for 10 quarters in a row: $497M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -5.2 points |
| Q2 2026 | 14% | +2.1 points |
| Q1 2026 | 5.7% | -5.6 points |
| Q4 2025 | 17% | -1 points |
| Q3 2025 | 18% | -0.2 points |
| Q2 2025 | 12% | -6.4 points |
| Q1 2025 | 11% | -6.4 points |
| Q4 2024 | 18% | -2.6 points |
CXT's operating margin was 13% last quarter, down 5.2 points from the same quarter a year ago.
CXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $90.2M | +15% |
| Q2 2026 | $73.4M | +32% |
| Q1 2026 | -$24.1M | +$8.1M |
| Q4 2025 | $96M | +37% |
| Q3 2025 | $78.7M | +47% |
| Q2 2025 | $55.8M | +16% |
| Q1 2025 | -$32.2M | -$29.2M |
| Q4 2024 | $70.3M | +11% |
CXT still generates free cash flow, though less than at its 2019 peak: $236M over the past year.
CXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.2% | +100K shares |
| 3 years | +1% | +600K shares |
| 5 years | -66% | -113M shares |
| Available history | -67% | -116M shares |
CXT has 58M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
| Q2 2021 | — |
CXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.6x | Healthy |
CXT's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
CXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.5 | Neutral |
| Stochastic | 73.0 | Neutral |
CXT's weekly RSI is 61 (neutral) and its Stochastic is 73 (neutral).
CXT PE vs Industrials Sector
| Metric | CXT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 7.8% above |
| PE % | 82 | 58 | 24 pts above |
CXT is trading at 26x earnings, in line with the Industrials sector's median of 24x.
CXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.0 | 5.6% above |
| 20 week MA | $52.2 | 9.2% above |
| 50 week MA | $48.8 | 17% above |
| 100 week MA | $53.1 | 7.3% above |
| 200 week MA | $54.1 | 5.4% above |
CXT has climbed back above all five of its weekly moving averages, and it's now 5.4% above its 200-week average.
CXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.0 | $26.7 | -11% |
| 2021 | $26.7 | $34.6 | +30% |
| 2022 | $34.6 | $34.6 | -0.2% |
| 2023 | $34.6 | $56.9 | +65% |
| 2024 | $56.9 | $58.0 | +2% |
| 2025 | $58.0 | $48.4 | -17% |
| 2026 YTD | $48.4 | $57.0 | +18% |
CXT has finished lower in three of the last six years. It's up 18% so far in 2026.